Similarly, DeveciOzkan A, et al. found that LNCaP (an AR/AR-V7-positive prostate cancer cell line) cells are more sensitive to nobiletin than PC3 cells and speculated that the difference may be related to AR. Here, AR is linked to prostate carcinoma.